Skip to main content
Erschienen in: memo - Magazine of European Medical Oncology 1/2019

11.10.2018 | case report

Kaposi sarcoma following autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia

verfasst von: Utku Iltar, M.D, Vedat Aslan, Mesut Gocer, Fatma Aykac, İlknur Nizam, Mehmet Çelik, Faruk Gulec, Turgay Ulaş, Erdal Kurtoğlu

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Summary

Background

Kaposi sarcoma is a low grade angioproliferative disorder which requires infection with human herpes virus 8 for its development. Skin lesions can be observed frequently in chronic lymphocytic leukemia cases, but there is a limited number of cases of Kaposi sarcoma with chronic lymphocytic leukemia in the literature.

Case report

Here, we present a case report of an iatrogenic Kaposi sarcoma in a 79-year-old man recently diagnosed with autoimmune hemolytic anemia secondary to chronic lymphocytic leukemia. After treatment with methylprednisolone and rituximab, the patient developed Kaposi sarcoma nodular lesions on his legs. After three courses of oral etoposide for Kaposi sarcoma, the lesions completely disappeared at the end of the third month of treatment.

Conclusion

Even though the mortality rate is low with Kaposi sarcoma, it can cause physical and psychological burden for the patients. Additional investigations and raising awareness of Kaposi sarcoma while evaluating the differential diagnosis of skin lesions in chronic lymphocytic leukemia are needed. Short-term oral etoposide was tolerated well in this patient with a good clinical response.
Literatur
1.
Zurück zum Zitat Douglas JL, Gustin JK, Dezube B, Pantanowitz JL, Moses AV. Kaposi’s sarcoma: a model of both malignancy and chronic inflammation. Panminerva Med. 2007;49(3):119–38.PubMed Douglas JL, Gustin JK, Dezube B, Pantanowitz JL, Moses AV. Kaposi’s sarcoma: a model of both malignancy and chronic inflammation. Panminerva Med. 2007;49(3):119–38.PubMed
3.
Zurück zum Zitat Hisada M, Biggar RJ, Greene MH, Fraumeni JF Jr, Travis LB. Solid tumors after chronic lymphocytic leukemia. Blood. 2001;98(6):1979–81.CrossRef Hisada M, Biggar RJ, Greene MH, Fraumeni JF Jr, Travis LB. Solid tumors after chronic lymphocytic leukemia. Blood. 2001;98(6):1979–81.CrossRef
4.
Zurück zum Zitat Hacioglu MB, Sahin S, Karatas F, Aytekin A. A rare coexistence—chronic lymphocytic leukemia and Kaposi sarcoma: case report and review of the literature. J Cancer Res Ther. 2015;11(4):954–6.CrossRef Hacioglu MB, Sahin S, Karatas F, Aytekin A. A rare coexistence—chronic lymphocytic leukemia and Kaposi sarcoma: case report and review of the literature. J Cancer Res Ther. 2015;11(4):954–6.CrossRef
5.
Zurück zum Zitat Wijermans PW, van Groningen K, van Royen EA, Bruijn JA. Kaposi’s sarcoma in an HIV-negative CLL patient as the cause of thrombocytopenia. Ann Hematol. 1994;68(6):307–10.CrossRef Wijermans PW, van Groningen K, van Royen EA, Bruijn JA. Kaposi’s sarcoma in an HIV-negative CLL patient as the cause of thrombocytopenia. Ann Hematol. 1994;68(6):307–10.CrossRef
6.
Zurück zum Zitat Kose F, Kocer NE, Sumbul AT, Sezer A, Yilkan O. Kaposi’s sarcoma following chronic lymphocytic leukemia: a rare entity. Case Rep Oncol. 2012;5(2):271–4.CrossRef Kose F, Kocer NE, Sumbul AT, Sezer A, Yilkan O. Kaposi’s sarcoma following chronic lymphocytic leukemia: a rare entity. Case Rep Oncol. 2012;5(2):271–4.CrossRef
7.
Zurück zum Zitat Contu L, Carcassi C, La Nasa G, Zurrida SM, Sirigu F, Del Giacco S, Cerimele D, Longinotti M, Pitzus F. A case of classical Kaposi’s sarcoma in B‑cell chronic lymphocytic leukemia (B-CLL). Tumori. 1986;72(4):365–74.CrossRef Contu L, Carcassi C, La Nasa G, Zurrida SM, Sirigu F, Del Giacco S, Cerimele D, Longinotti M, Pitzus F. A case of classical Kaposi’s sarcoma in B‑cell chronic lymphocytic leukemia (B-CLL). Tumori. 1986;72(4):365–74.CrossRef
8.
Zurück zum Zitat Wang QJ, Jenkins FJ, Jacobson LP, Kingsley LA, Day RD, Zhang ZW, Meng YX, Pellett PE, Kousoulas KG, Baghian A, Rinaldo CR Jr.. Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T‑cell response to viral lytic cycle proteins. Blood. 2001 Apr 15;97(8):2366–73. Erratum. Blood. 2002;99(10):3499. Wang QJ, Jenkins FJ, Jacobson LP, Kingsley LA, Day RD, Zhang ZW, Meng YX, Pellett PE, Kousoulas KG, Baghian A, Rinaldo CR Jr.. Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T‑cell response to viral lytic cycle proteins. Blood. 2001 Apr 15;97(8):2366–73. Erratum. Blood. 2002;99(10):3499.
9.
Zurück zum Zitat Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA. 1975;232(3):267–9.CrossRef Manusow D, Weinerman BH. Subsequent neoplasia in chronic lymphocytic leukemia. JAMA. 1975;232(3):267–9.CrossRef
10.
Zurück zum Zitat Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL, Otley CC. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia. Int J Dermatol. 2015;54(8):e287–e93.CrossRef Brewer JD, Shanafelt TD, Call TG, Cerhan JR, Roenigk RK, Weaver AL, Otley CC. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia. Int J Dermatol. 2015;54(8):e287–e93.CrossRef
Metadaten
Titel
Kaposi sarcoma following autoimmune hemolytic anemia in a patient with chronic lymphocytic leukemia
verfasst von
Utku Iltar, M.D
Vedat Aslan
Mesut Gocer
Fatma Aykac
İlknur Nizam
Mehmet Çelik
Faruk Gulec
Turgay Ulaş
Erdal Kurtoğlu
Publikationsdatum
11.10.2018
Verlag
Springer Vienna
Erschienen in
memo - Magazine of European Medical Oncology / Ausgabe 1/2019
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI
https://doi.org/10.1007/s12254-018-0445-6

Weitere Artikel der Ausgabe 1/2019

memo - Magazine of European Medical Oncology 1/2019 Zur Ausgabe